Aspiriant LLC’s Vanguard Growth ETF VUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39M Sell
74,004
-3,498
-5% -$272K 0.15% 67
2025
Q4
$6.3M Buy
77,502
+864
+1% +$70.1K 0.18% 62
2025
Q3
$6.13M Buy
76,638
+4,932
+7% +$377K 0.19% 55
2025
Q2
$5.24M Hold
71,706
0.17% 61
2025
Q1
$4.43M Sell
71,706
-6,918
-9% -$466K 0.15% 59
2024
Q4
$5.38M Sell
78,624
-7,380
-9% -$496K 0.19% 56
2024
Q3
$5.5M Buy
86,004
+1,752
+2% +$109K 0.21% 52
2024
Q2
$5.25M Buy
84,252
+19,128
+29% +$1.12M 0.21% 54
2024
Q1
$3.74M Sell
65,124
-564
-0.9% -$31K 0.15% 64
2023
Q4
$3.4M Sell
65,688
-270
-0.4% -$13K 0.15% 66
2023
Q3
$2.99M Buy
65,958
+6,600
+11% +$312K 0.15% 69
2023
Q2
$2.8M Sell
59,358
-9,774
-14% -$424K 0.14% 73
2023
Q1
$2.87M Buy
69,132
+8,004
+13% +$311K 0.15% 74
2022
Q4
$2.17M Sell
61,128
-8,808
-13% -$324K 0.11% 84
2022
Q3
$2.49M Sell
69,936
-246
-0.4% -$9.89K 0.12% 72
2022
Q2
$2.61M Buy
70,182
+192
+0.3% +$7.89K 0.13% 73
2022
Q1
$3.35M Buy
69,990
+9,510
+16% +$450K 0.18% 63
2021
Q4
$3.23M Sell
60,480
-2,796
-4% -$146K 0.17% 66
2021
Q3
$3.06M Buy
63,276
+2,016
+3% +$100K 0.18% 58
2021
Q2
$2.93M Buy
61,260
+13,692
+29% +$622K 0.17% 64
2021
Q1
$2.04M Buy
47,568
+31,836
+202% +$1.36M 0.13% 66
2020
Q4
$664K Sell
15,732
-828
-5% -$33K 0.05% 133
2020
Q3
$628K Sell
16,560
-222
-1% -$8.2K 0.05% 137
2020
Q2
$565K Buy
16,782
+726
+5% +$22.3K 0.05% 123
2020
Q1
$419K Sell
16,056
-198
-1% -$5.93K 0.04% 133
2019
Q4
$493K Hold
16,254
0.05% 138
2019
Q3
$451K Sell
16,254
-78
-0.5% -$2.16K 0.04% 154
2019
Q2
$445K Sell
16,332
-15,900
-49% -$425K 0.04% 158
2019
Q1
$840K Buy
32,232
+3,972
+14% +$98K 0.07% 121
2018
Q4
$633K Sell
28,260
-1,500
-5% -$36.3K 0.05% 131
2018
Q3
$798K Hold
29,760
0.07% 121
2018
Q2
$743K Sell
29,760
-29,130
-49% -$714K 0.06% 130
2018
Q1
$1.39M Buy
+58,890
New +$1.44M 0.12% 86
2016
Q3
Sell
-21,204
Closed -$379K 203
2016
Q2
$379K Buy
21,204
+7,278
+52% +$130K 0.04% 151
2016
Q1
$247K Hold
13,926
0.02% 155
2015
Q4
$247K Sell
13,926
-45,252
-76% -$811K 0.03% 72
2015
Q3
$1.02M Buy
59,178
+31,326
+112% +$555K 0.08% 54
2015
Q2
$497K Buy
+27,852
New +$506K 0.05% 75
2014
Q1
Sell
-15,096
Closed -$234K 86
2013
Q4
$234K Sell
15,096
-12,456
-45% -$184K 0.04% 67
2013
Q3
$389K Sell
27,552
-14,292
-34% -$197K 0.07% 38
2013
Q2
$545K Buy
+41,844
New +$552K 0.09% 46

Other funds holding VUG

Aspiriant LLC's VUG Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Growth ETF (VUG) stake by 4.5% in Q1 2026, selling an estimated $272K and leaving 74,004 shares worth $5.39M. The position accounts for 0.15% of the portfolio, ranked #67.

Aspiriant LLC first reported a position in VUG in Q2 2013 and has held it in 41 quarters since. The position peaked at $6.3M in Q4 2025. 2,720 funds tracked by Wall St. Rank hold VUG as of Q1 2026.

  • Aspiriant LLC held 74,004 shares of Vanguard Growth ETF worth $5.39M as of Q1 2026.
  • Aspiriant LLC sold 3,498 Vanguard Growth ETF shares in Q1 2026, an estimated $272K.
  • Vanguard Growth ETF made up 0.15% of Aspiriant LLC's portfolio in Q1 2026, its #67 holding.
  • Aspiriant LLC first reported a position in Vanguard Growth ETF in Q2 2013 and has held it in 41 quarters since.
  • Aspiriant LLC's Vanguard Growth ETF position peaked at $6.3M in Q4 2025.
  • 2,720 funds tracked by Wall St. Rank held Vanguard Growth ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.